CAD 0.01
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -13.36 Million CAD | 26.03% |
2022 | -18.06 Million CAD | -187.33% |
2021 | -6.28 Million CAD | 68.59% |
2020 | -20.01 Million CAD | -8.0% |
2019 | -18.53 Million CAD | -217.12% |
2018 | -5.84 Million CAD | -113.74% |
2017 | -2.73 Million CAD | 25.59% |
2016 | -3.67 Million CAD | -8897.33% |
2015 | -40.84 Thousand CAD | 0.0% |
2013 | -1.03 Million CAD | -560.97% |
2012 | -155.89 Thousand CAD | 72.37% |
2011 | -564.16 Thousand CAD | -271.15% |
2010 | -152 Thousand CAD | -148.9% |
2009 | -61.07 Thousand CAD | -105.55% |
2008 | -29.71 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 16.69 Thousand CAD | 102.25% |
2024 Q2 | -741.28 Thousand CAD | -104.33% |
2024 Q1 | -362.78 Thousand CAD | 95.87% |
2023 FY | -13.36 Million CAD | 26.03% |
2023 Q1 | -1.16 Million CAD | 70.25% |
2023 Q2 | -359.19 Thousand CAD | 69.22% |
2023 Q3 | -3.12 Million CAD | -769.62% |
2023 Q4 | -8.77 Million CAD | -180.89% |
2022 Q1 | -952.79 Thousand CAD | 65.57% |
2022 FY | -18.06 Million CAD | -187.33% |
2022 Q3 | -12.37 Million CAD | -1384.01% |
2022 Q4 | -3.92 Million CAD | 68.31% |
2022 Q2 | -833.91 Thousand CAD | 12.48% |
2021 Q4 | -2.76 Million CAD | -811.17% |
2021 Q3 | 389.1 Thousand CAD | 127.61% |
2021 FY | -6.28 Million CAD | 68.59% |
2021 Q2 | -1.4 Million CAD | 47.49% |
2021 Q1 | -2.68 Million CAD | 61.74% |
2020 FY | -20.01 Million CAD | -8.0% |
2020 Q1 | -3.75 Million CAD | 31.24% |
2020 Q2 | -6.13 Million CAD | -63.33% |
2020 Q3 | -4.63 Million CAD | 24.49% |
2020 Q4 | -7.01 Million CAD | -51.31% |
2019 Q2 | -2.92 Million CAD | 3.72% |
2019 Q4 | -5.46 Million CAD | 22.65% |
2019 FY | -18.53 Million CAD | -217.12% |
2019 Q1 | -3.04 Million CAD | 19.81% |
2019 Q3 | -7.06 Million CAD | -141.38% |
2018 Q1 | -628.45 Thousand CAD | 68.78% |
2018 FY | -5.84 Million CAD | -113.74% |
2018 Q4 | -3.79 Million CAD | -539.32% |
2018 Q3 | -592.98 Thousand CAD | 28.76% |
2018 Q2 | -832.34 Thousand CAD | -32.44% |
2017 Q1 | -113.29 Thousand CAD | 94.03% |
2017 Q4 | -2.01 Million CAD | -268.67% |
2017 FY | -2.73 Million CAD | 25.59% |
2017 Q3 | -545.98 Thousand CAD | -128.36% |
2017 Q2 | -239.08 Thousand CAD | -111.04% |
2016 Q2 | -722.81 Thousand CAD | -285.69% |
2016 Q1 | -187.4 Thousand CAD | -384.31% |
2016 FY | -3.67 Million CAD | -8897.33% |
2016 Q4 | -1.89 Million CAD | -721.84% |
2016 Q3 | -230.75 Thousand CAD | 68.08% |
2015 Q4 | -38.69 Thousand CAD | 33.32% |
2015 FY | -40.84 Thousand CAD | 0.0% |
2015 Q3 | -58.03 Thousand CAD | -166.91% |
2015 Q2 | -21.74 Thousand CAD | -151.36% |
2015 Q1 | -8650.00 CAD | 79.25% |
2014 Q3 | -16.45 Thousand CAD | 98.31% |
2014 Q4 | -41.69 Thousand CAD | -153.3% |
2014 Q1 | -16.61 Thousand CAD | -35.44% |
2014 Q2 | -973.82 Thousand CAD | -5761.48% |
2013 Q3 | -27.71 Thousand CAD | 60.83% |
2013 Q4 | -12.26 Thousand CAD | 55.75% |
2013 FY | -1.03 Million CAD | -560.97% |
2013 Q1 | -29.07 Thousand CAD | -18.18% |
2013 Q2 | -70.76 Thousand CAD | -143.42% |
2012 Q4 | -24.59 Thousand CAD | 21.8% |
2012 Q1 | -52.57 Thousand CAD | 49.32% |
2012 Q2 | -184.97 Thousand CAD | -251.86% |
2012 Q3 | -31.45 Thousand CAD | 82.99% |
2012 FY | -155.89 Thousand CAD | 72.37% |
2011 Q2 | -97.04 Thousand CAD | -169.05% |
2011 Q4 | -103.74 Thousand CAD | 53.45% |
2011 Q3 | -222.87 Thousand CAD | -129.67% |
2011 FY | -564.16 Thousand CAD | -271.15% |
2011 Q1 | -36.06 Thousand CAD | -343.82% |
2010 Q2 | -23.5 Thousand CAD | -12.69% |
2010 FY | -152 Thousand CAD | -148.9% |
2010 Q4 | -8127.00 CAD | 24.51% |
2010 Q3 | -10.76 Thousand CAD | 54.21% |
2010 Q1 | -20.85 Thousand CAD | -248.87% |
2009 Q1 | -15.72 Thousand CAD | 0.0% |
2009 Q4 | -5979.00 CAD | 44.26% |
2009 Q3 | -10.72 Thousand CAD | 0.0% |
2009 FY | -61.07 Thousand CAD | -105.55% |
2008 FY | -29.71 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aion Therapeutic Inc. | -6.28 Million CAD | -112.558% |
Ayurcann Holdings Corp. | -3.96 Million CAD | -236.815% |
Blueberries Medical Corp. | -1.63 Million CAD | -717.178% |
The BC Bud Corporation | -1.22 Million CAD | -991.774% |
BioNxt Solutions Inc. | -7.72 Million CAD | -73.042% |
CordovaCann Corp. | -6.88 Million CAD | -94.111% |
Christina Lake Cannabis Corp. | -4.13 Million CAD | -223.439% |
Captor Capital Corp. | -11.38 Million CAD | -17.423% |
City View Green Holdings Inc. | -2.44 Million CAD | -445.78% |
1CM Inc. | -913.85 Thousand CAD | -1362.364% |
Global Hemp Group Inc. | -2.58 Million CAD | -417.874% |
Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -182.974% |
IM Cannabis Corp. | -9.49 Million CAD | -40.702% |
Lobe Sciences Ltd. | -4.7 Million CAD | -183.895% |
Maple Leaf Green World Inc. | -1.09 Million CAD | -1124.333% |
Mountain Valley MD Holdings Inc. | -7.67 Million CAD | -74.236% |
Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 6083.827% |
Ovation Science Inc. | -813.14 Thousand CAD | -1543.477% |
Pharmadrug Inc. | -13.2 Million CAD | -1.232% |
Captiva Verde Wellness Corp. | -6.08 Million CAD | -119.617% |
RAMM Pharma Corp. | -7.72 Million CAD | -73.087% |
RIV Capital Inc. | -106.76 Million CAD | 87.482% |
Revive Therapeutics Ltd. | -5.61 Million CAD | -137.85% |
Red White & Bloom Brands Inc. | -138.89 Million CAD | 90.379% |
SLANG Worldwide Inc. | -19.36 Million CAD | 30.994% |
Red Light Holland Corp. | -7.62 Million CAD | -75.212% |
Top Strike Resources Corp. | -1.72 Million CAD | -676.958% |
Xebra Brands Ltd. | -1.95 Million CAD | -582.745% |
Adastra Holdings Ltd. | -3.54 Million CAD | -277.017% |